Project Grant HT94252510221
Award Date
8/1/25
Completion Date
7/31/29
Dollars Obligated
$1.3M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Chicago, IL 60637, USA
Similar Awards
The University of Chicago has been awarded a $869,193 federal Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, effective July 1, 2025 through June 30, 2028, supports research to identify the pathogenesis of monosomy 7 in bone marrow failure. This project aims to advance scientific understanding and develop innovative approaches to prevent, diagnose, and treat conditions relevant to military personnel and the...
This federal Project Grant award, valued at $1,312,000.00, was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant will fund the University of Chicago's project to adapt an inhaled substance use intervention for adolescent and young adult cancer survivors. The project aims to transform healthcare for military service members and the broader public by developing innovative approaches to address substance use challenges faced...
This federal Project Grant award of $820,000.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) was provided to the University of Chicago to conduct research on "Determining and Exploiting Metabolic Vulnerabilities of Cancer-Associated Fibroblast Heterogeneity." The research project aims to explore metabolic differences within cancer-associated fibroblasts and leverage those findings to develop new therapeutic approaches. The...
The federal Project Grant award, with ID HT94252510182, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The $1,306,991.00 award, with a performance period from Aug 1, 2025 to Jul 31, 2029, is funding research at the University of Texas MD Anderson Cancer Center to develop organoid-based models and therapeutic approaches for TP53-mutated acute myeloid leukemia. This research aims to transform healthcare for...
The University of Chicago was awarded a $2,624,000.00 Project Grant from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) to fund the research project "TARGETING TISSUE-RESIDENT ALVEOLAR MACROPHAGE METABOLISM IN ACUTE LUNG INJURY". This four-year grant, running from April 1, 2024 to March 31, 2028, supports cutting-edge biomedical research aimed at improving health outcomes for military service members, veterans, and their families. The research...
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $1,612,104.00 to the University of Chicago to develop and evaluate "senescent tumor cell-loaded dendritic cell vaccines for breast cancer." The award, which runs from February 1, 2025 through January 31, 2028, supports advanced medical research to transform healthcare for military service members and the broader public....
The University of Chicago will receive $1,229,184 from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) from July 1, 2022 to June 30, 2025. The funding will support research into microRNA-mediated regulation of prostate cancer biology. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical research solutions for battlefield medicine. The University of...
This federal Project Grant award, valued at $650,845.00 and provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports macrophage-centric prognostic biomarker research for checkpoint blockade immunotherapy in melanoma. The award, effective July 1, 2025, will fund advanced biomedical research initiatives at the University of Alabama at Birmingham (UAB) aimed at transforming healthcare for military service members and the broader...
The Defense Health Agency awarded a $159,892 Project Grant to the University of Illinois under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant supports research into "Metabolic Vulnerabilities Associated to G12C Inhibitor Resistance" from January 1, 2022 through December 31, 2023. The Military Medical Research and Development program aims to transform military and public health through innovative medical research solutions. This award will...
This federal Project Grant award, valued at $1,235,845.00 and awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports advanced biomedical research to deliver individualized treatment effects in metastatic hormone sensitive prostate cancer. The project, with a performance period from August 15, 2025 to August 14, 2028, will leverage data science methods to transform healthcare for military service members and the broader public. The...